This meeting has kicked for an intense discussion on epidemics research focusing on mpox

And the same spirit of thanks to the team from Catholic University of Bukavu UCB DRC who educated us on clinical manifestation of Mpox. Thanks too to all delegates from Burundi, Gabon, Central African Republic, Kenya, Tanzania, Uganda, Zambia, UK & global community online.

Catholic University of Bukavu - Democratic Republic of Congo - Center for Tropical Diseases and Global Health Esto Bahizire, MD, PhD Co-founder and Director Dr. Bahizire is a medical doctor trained in Medical Microbiology (Univ. of Nairobi) and in Epidemiology-Public Health

The latest Situation Report on the multi-country #mpox outbreak is now available. ✅Regional epidemiological updates ✅Country-specific trends & transmission patterns ✅Response efforts Read the full update: bit.ly/4cioJcG who.int/publications/m…

Mpox is a serious public health threat in Africa, especially in DR Congo. A new study provides a clinical comparison of mpox cases in DR Congo regions where clade 1a and clade 1b are prevalent: hubs.li/Q03hnGhK0

Amos Makala ameburuzwa Mahakamani kijinai kwa kauli zake za kizandiki ati CDM kimenunua virusi vya MPOX na UVIKO 19. Kazi kwake. Na iwe fundisho.

Happening now: A joint WHO/AFRICA CDC Incident Management & Support Team on Mpox visits Uganda’s Ministry of Health, Ministerial SAC, and the Research Pillar. Ministry of Health- Uganda Makerere University College of Health Sciences Bruce Kirenga Winters Muttamba Themba 🇺🇬🇷🇼 Wilber Sabiiti Africa CDC Makerere University Lung Institute MRC/UVRI and LSHTM Uganda Research Unit @

Delighted to our University of St Andrews Doctoral scholar Winters Muttamba Themba 🇺🇬🇷🇼 presenting the research we are doing under ICER Interdisciplinary Consortium 4 Epidemics Research Makerere University Lung Institute Infection St Andrews Africa CDC Global Health EDCTP3 Makerere University College of Health Sciences

Eight (8) global research studies are underway with partners across Africa, Europe, and Canada. While some work awaits funding, these projects underscore ICER’s growing impact on epidemic research. Winters Muttamba Themba 🇺🇬🇷🇼 Africa CDC Wilber Sabiiti Misaki Wayengera Bruce Kirenga

Mpox isn’t just a health crisis, it’s a research opportunity. Uganda, through ICER, is building Africa led evidence to shape global Mpox policy and vaccine strategy. Science rooted in the region, shared with the world. Ministry of Health- Uganda Ministry of Health- Uganda Bruce Kirenga Wilber Sabiiti

The ICER Co-Chair Wilber Sabiiti appeals to Africa CDC and partners to support countries to conduct serological and ecological studies where feasible. These are key to understanding transmission dynamics, immunity gaps, and guiding vaccine strategy. Mosoka P Fallah Makerere University Lung Institute

Cross border transmission continues to influence Mpox case numbers, highlighting the need for enhanced regional surveillance, collaboration, and shared vigilance across affected countries. Ministry of Health- Uganda Bruce Kirenga Africa CDC Mosoka P Fallah Wilber Sabiiti Winters Muttamba Themba 🇺🇬🇷🇼 Misaki Wayengera

Congratulations to one of our sister projects being implemented in DRC, Uganda, and Tanzania for achieving the Uganda set sample size

Prof Bruce Kirenga, the PI for PREGMPOX in Uganda shares efforts made in the past 2 years by ICER to generate evidence that informs response to not only Mpox but Ebola and COVID-19

Dr Susanne Krasemann represented the study at the CRC1648 Pandemic Preparedness Symposium, presenting preliminary results on the Impact of MPXV infection on pregnancy outcomes and newborn health, which was fully initiated in November 2024 in the DRC under the lead of Prof. Katoto

#Mpox vs. Chickenpox: What's the difference? Both cause rashes but differ in cause, transmission and severity. Learn how to spot the symptoms and protect yourself. Stay informed!

Join the European Research and Innovation Days 2025! 📅 16–17 September 📍 Brussels & online Our Executive Director in the session: Making the EU the Most Attractive Place for Life Sciences 👉 Register: research-and-innovation.ec.europa.eu/events/europea… #RiDaysEU EU Science & Innovation 🇪🇺 Horizon Europe 🇪🇺

We are happy to share our recent article about vertical transmission among three cases of clade Ib MPXV infection in pregnant women assessed using molecular and histopathological evidence of transplacental transmission across all trimesters in DRC nejm.org/doi/10.1056/NE…

Nous partageons notre article sur trois cas de transmission verticale du MPXV clade Ib chez des femmes enceintes en DRC, confirmée par des preuves moléculaires et histopathologiques de transmission transplacentaire à tous les trimestres. nejm.org/doi/10.1056/NE…